Latest filing published 19 Feb 2026 for Immunocore Holdings plc.
David M. Berman appears in our data through filings on Immunocore Holdings plc shares, published by SEC (Form 4). We count 39 filings; the first trade dates from 26 February 2024 and the latest from 18 February 2026.
No open-market purchase appears, only 24 sales worth €16.4M. Outside the open market, there are 15 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
Most recently, on 19 February 2026, the filings show an open-market sale worth €163k in Immunocore Holdings plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations